{"id":"chemotheraoy-along","safety":{"commonSideEffects":[{"rate":"30-50%","effect":"Neutropenia"},{"rate":"20-40%","effect":"Nausea and vomiting"},{"rate":"10-30%","effect":"Fatigue"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Chemotheraoy along is a chemotherapeutic agent that interferes with DNA replication and transcription, ultimately leading to cell death. This mechanism is particularly effective against rapidly dividing cancer cells. The exact molecular target of Chemotheraoy along is not well-characterized.","oneSentence":"Chemotheraoy along works by inhibiting cell division in rapidly proliferating cancer cells.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:44:53.982Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Metastatic non-small cell lung cancer"}]},"trialDetails":[{"nctId":"NCT05230771","phase":"PHASE3","title":"Clinical Outcome of Palliative Surgery After Translational Therapy for Metastatic Gastric Cancer Versus Maintenance Chemotherapy for Metastatic Gastric Cancer","status":"NOT_YET_RECRUITING","sponsor":"Fujian Medical University","startDate":"2022-04-01","conditions":"Metastatic Gastric Cancer, Surgery, Chemotherapy","enrollment":120}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Chemotheraoy along","genericName":"Chemotheraoy along","companyName":"Fujian Medical University","companyId":"fujian-medical-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Chemotheraoy along works by inhibiting cell division in rapidly proliferating cancer cells. Used for Metastatic non-small cell lung cancer.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}